Synthetic Artificial Stem Cells (SASC)

  • New class of stem cell therapy
  • Mitigates the risk of traditional stem cell therapy
  • Fabrication of SASC decreases the time for patient therapy by circumventing the need to expand and culture autologous cells in vitro before injecting them back into the patient

Contact Information

Name: Christopher Conners

Email: christopher.conners@uconn.edu

Phone: 860-679-8772